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ABSTRACT (224 words) 
A subcategory of medical tourism, reproductive tourism has been the subject of much public 
and policy debate in recent years. Specific concerns include the exploitation of individuals and 
communities, access to needed health care services, fair allocation of limited resources, and the 
quality and safety of services provided by private clinics. To date, the focus of attention has 
been on the thriving medical and reproductive tourism sectors in Asia and Eastern Europe; 
there has been much less consideration given to more recent ‘players’ in Latin America, notably 
fertility clinics in Chile, Brazil, Mexico and Argentina. In this paper, we explore the case of 
private Argentinean fertility clinics that market reproductive services via the Internet, to examine 
the context-specific ethical and policy implications. Whether or not one agrees that reproductive 
services should be made available as consumer goods, the fact is that they are provided as 
such by private clinics around the world. We argue that basic national regulatory mechanisms 
are required in countries such as Argentina that are marketing fertility services to local and 
international publics. Specifically, regular oversight of all fertility clinics is essential to ensure 
that consumer information is accurate and that marketed services are safe and effective. It is in 
the best interests of consumers, health professionals and policy makers that the reproductive 
tourism industry adopt safe and responsible medical practices. 
 
Keywords: reproductive technologies, fertility, medical tourism, Argentina, private clinics, 
regulation 
Text: 6085 words 
 
 
BACKGROUND 
‘Health’ or ‘medical’ tourism are terms used to describe the travel of consumers from one 
jurisdiction to another to purchase health care services.1 For example, Canadians are visiting 
the United States to access services not covered by their public health care system; Americans 
are going to Mexico to obtain alternative therapies or cheaper medications; and the British are 
visiting India to avoid lengthy waits for heart or knee surgeries. Such forms of medical tourism 
are not new, but what is new is the significant increase in the number of countries involved in 
medical tourism and the level of activity relating to this business. 
 
In recent years, the practice of medical tourism has been the subject of significant public 
debate, as well as academic and policy analyses.2 Much publicized cases of medical negligence 
(and subsequent malpractice lawsuits) – due in part to the wide variation in or even absence of 
regulation and legal frameworks – have attracted attention and raised concerns for consumers 
and health professionals.3 Discrepancies in how countries regulate and compensate patients 
affected by medical malpractice are particularly worrisome. For example, legislative frameworks 
in India allow for the provision of very modest compensation to patients, when compared with 
                                            
1 H. Widdows. Is Global Ethics Moral Neo-Colonialism? An Investigation of the Issue in the Context of 
Bioethics. Bioethics 2007; 21: 305-315 
2 R. Marcelo. 2003. India Fosters Growing 'Medical Tourism' Sector. The Financial Times 2 Jul. Available 
at: http://yaleglobal.yale.edu/display.article?id=2016 [Accessed 8 Oct 2008]; J. Cherian. 2006. 
Accreditation of Hospitals to Promote Top Medical Tourism Destination in India. All Headline News 27 
July. Available at: http://www.allheadlinenews.com/articles/7004351049 ; J. Frenk & O. Gomez-Dantes. 
Globalization and the Challenges to Health Systems. Health Aff 2002; 21: 160-165.  
3 G. Semenza. 2007. The Medical Tourist: U.S. Doctors Warn About the Dangers of Cheap Surgeries in 
Foreign Countries. Victoria Advocate June 17 
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much more generous provisions available in most Western countries.4 The average medical 
tourist is also likely ill informed as to the specifics of malpractice laws in foreign countries, and it 
is doubtful whether they would even have legal recourse in the event of negligent treatment.5 
Such legal information is often not readily available to consumers (e.g. not posted on medical 
tourism websites, possibly in an unfamiliar language), and they might thus reasonably, if 
incorrectly, assume that they are protected by similar legal mechanisms as in their home 
countries. 
 
Opponents of medical tourism assert that it benefits only the wealthy and allows people to ‘jump 
the queue’ to unfairly receive services that less affluent individuals, either in the host country or 
in foreign jurisdictions, cannot afford to purchase. The underlying principle is that access to 
needed health care is a basic human right or a fundamental good and should not be managed 
or provided as a free market commodity like any other.6 Critics point out that medical tourism 
undermines this public good; free market dynamics create economic vulnerability for poorer 
countries who must use their health care systems to generate wealth by targeting foreign 
consumer demand for technology-intensive tertiary care, instead of providing essential primary 
health care for their citizens.7 
 
Those who advocate in favour of medical tourism assert that there is little need to worry about 
autonomous consumers who have the financial means to seek out health care in foreign 
nations; as wealthy individuals, they have the power to ‘shop around’ and evaluate the risks and 
benefits of various services, and so should be able to freely purchase those services and 
products they desire. Also, the point is made that the health care industry is economically 
important in both developed and developing countries and thus ought to be encouraged for the 
economic benefit of all citizens.8  
 
Reproductive Tourism in Latin America 
Although there are many categories of medical tourism, we will limit our analysis to the provision 
of fertility services, or reproductive tourism, a subcategory of medical tourism that is receiving 
increased attention.9 For the most part, reproductive tourism has been directed at wealthy North 
American or European couples who travel to other developed countries to access assisted 
reproductive technologies (ART) such as in-vitro fertilization (IVF) or pre-implantation genetic 
diagnosis (PGD). The main interest for these individuals to become medical tourists is the high 
cost, the long waiting lists, or even the absence of ART services at home;10 prominent examples 
include UK couples visiting the US to obtain PGD and IVF to conceive so-called ‘saviour sibling’ 
children (a child who will be an immuno-compatible match and supply a life-saving tissue – 
commonly umbilical stem cells – to a gravely ill sibling).11 
  
                                            
4 R. Bhat. Regulating the Private Health Care Sector: The Case of the Indian Consumer Protection Act. 
Health Policy Plan 1996; 11: 265-279 
5 P. Mirrer-Singer. Medical Malpractice Overseas: The Legal Uncertainty Surrounding Medical Tourism. 
Law Contemp Probl 2007; 70: 211-232 
6 N. Daniels. Justice, Health, and Health Care. Am J Bioeth 2001; 1: 2-16 
7 A.B. Ramirez de Arellano. Patients without Borders: The Emergence of Medical Tourism. Int J Health 
Serv 2007; 37: 193-198 
8 B. Starfield. Improving Equity in Health: A Research Agenda. Int J Health Serv 2001; 31: 545-566 
9 G. Pennings. Reproductive Tourism as Moral Pluralism in Motion Br Med J 2002; 28: 337-341 
10 E. Blyth & A. Farrand. Reproductive Tourism - a Price Worth Paying for Reproductive Autonomy? 
Critical Social Policy 2005; 25: 91-114 
11 M. Spriggs & J. Savulescu. "Saviour Siblings". J Med Ethics 2002; 28: 289 
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In the last 10 years, private fertility clinics have appeared in developing countries, offering a 
wide variety of fertility services at much lower prices than clinics in developed countries.12 While 
the ‘big players’ in medical tourism, such as India and Poland, are actively involved in the fertility 
sector, so too now are Latin American countries such as Brazil, Chile, Mexico and Argentina. As 
with their North American, European and Asian counterparts, private fertility clinics in Latin 
America are using the Internet to reach potential consumers in the lucrative global market for 
assisted reproductive services. Next to Brazil and Mexico, Argentina is the Latin American 
country with the most well-established private fertility industry. It is the latest ‘new player’ in the 
medical tourism industry and it has become a highly sought after and affordable destination for 
medical tourists, particularly following the strong devaluation of the peso in 2002, which had 
previously been at parity with the American dollar.13 
 
Most fertility clinics in Argentina are private entities as there are very few public providers; 
access to some fertility services is covered by public or private health insurance plans, but for 
the most part these services necessitate direct out-of-pocket payment by patients. Many of 
these private fertility clinics appear to operate on a cost-recovery basis instead of a profit-
seeking business model. Nonetheless, as we will show, discrepancies between Argentinean 
fertility clinics, in terms of their service provision and marketing tactics, reveal an emerging 
divide between those clinics offering health services to local patients, and those concentrating 
on the provision of services for foreign clients. This divide or targeted specialization of clientele 
raises several ethical concerns. In particular, we identify questionable marketing and business 
practices on the part of clinics that cater to medical tourists. These practices raise concerns 
about adequate informed consent, marketing of health products as consumer goods, and 
corporate and professional responsibility. 
 
In absence of international moral consensus about the acceptability of reproductive tourism, this 
sector of the medical tourism industry (as well as the industry more generally) has remained 
poorly regulated. Whether one is an opponent or an advocate of reproductive tourism, the fact is 
that it is already a common practice and stopping it would seem unrealistic. This reality in no 
way undermines the need for policies and guidelines to ensure the safe and effective provision 
of medical services. However, as is well illustrated by the enormous variation in judicial and 
policy responses to developments in stem cell research, there will be very important regional 
differences in policy and public debate that will turn on religious, cultural, political, institutional 
and historical factors.14 No single country can simply copy the policy and regulatory mechanism 
of another to deal with the local challenges posed by biotechnology innovations. Reproductive 
tourism is no exception. 
 
In this paper, we aim to participate in the ethics and policy debate about the regulation of 
reproductive tourism. To do so, we begin by presenting the results of a comparative website 
analysis of Argentinean fertility clinics, so as to: 1) better understand the diversity of this private 
sector; 2) distinguish specific differences in service provision; and 3) reflect on the implications 
for health care consumers, professionals and policy makers. We conclude by suggesting some 
general guidelines for improving regulation in Argentina. In particular, we highlight the need to 
consider the specific cultural and moral entities of a country in the process of developing 
                                            
12 K. Evans & A.E.S. Samson. 2004. Facing the Challenges of New Reproductive Technologies. Young 
Women and Leadership. 8. Available at: http://www.iwtc.org/ideas/4_facing.pdf [Accessed 8 Oct 2008]. 
13 MedRetreat. 2008. Argentina. Available at: http://www.medretreat.com/destinations/argentina.html 
[Accessed 8 Oct 2008]. 
14 R.M. Isasi & B.M. Knoppers. Mind the Gap: Policy Approaches to Embryonic Stem Cell and Cloning 
Research in 50 Countries. Eur J Health Law 2006; 13: 9-26 
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regulation to mitigate the negative implications associated with the growing reproductive tourism 
industry. 
 
METHODS & RESULTS 
Our study, which was conducted in July and August 2007, involved two steps: 1) a detailed 
search of Latin American registries of fertility clinics, and 2) a general web search, using the 
Google® and Yahoo® search engines, for Argentinean fertility clinics.   
 
1) Registries for Latin American fertility clinics 
There are two main registries that have developed guidelines applicable to Argentinean fertility 
clinics: The Sociedad Argentina de Medicina Reproductiva (SAMeR) and the Registro 
Latinoamericano de Reproducción Asistida (RLA). SAMeR oversees the operations of clinics, 
regulates service quality, laboratory procedures and staff qualifications in Argentina.15 This 
oversight is comparable, yet more limited than that of the RLA, which oversees procedures 
performed in 141 fertility clinics throughout Latin America. We focused our analysis on the data 
included in the RLA since their registry is more comprehensive than that of SAMeR. 
 
The RLA is maintained by the Latin America Network of Assisted Reproduction (Red 
Latinoamericana de Reproduccion Asistida, REDLARA).16 REDLARA is a scientific and 
educational body that provides oversight of fertility services through the compilation of an 
annual catalogue of clinics from across Latin America. These clinics are registered or sub-
classified as either ‘affiliated’ or ‘accredited’. Accredited clinics are those that have submitted 
data to REDLARA that indicate an appropriate level of quality control and adherence to 
procedural guidelines. Parameters include information regarding: controls used to monitor 
laboratory quality, use of model client informed consent forms, descriptions of laboratory 
equipment, and descriptions of the clinical installations.17 Upon submission of this data, 
inspectors who are members of REDLARA – typically clinicians or biologists known to have no 
vested interest in the clinic – inspect the facility to validate the data submitted for accreditation. 
If discrepancies are identified but deemed not particularly grave, the clinic will be classified as 
‘affiliated’; the clinic then has three years to rectify inadequacies to obtain full accreditation. In 
summary, accreditation implies that a clinic is operating under accepted norms of practice, while 
affiliated clinics are in the process of reaching this gold standard. 
 
It would seem logical to assume that, in the case of medical tourism, RLA accreditation status 
might influence a consumer’s choice as to which clinic they would prefer to visit for treatment. 
Although not likely to be widely known by health care consumers (the information on the RLA 
website is geared towards health professionals), the RLA is a potentially very useful search 
instrument; its website was easily accessible in our Google searches for information concerning 
the regulation of fertility clinics. A link to this registry is also provided on the websites of the 
World Health Organization and the Pan American Health Organization. Table 1 (below) lists the 
subset of Argentinean fertility clinics included in the RLA, with a summary of the services 
provided, accreditation status, and website language. 
 
                                            
15 SAMeR. Sociedad Argentina De Medicina Reproductiva. Available at: http://www.samer.org.ar/ 
[Accessed 8 Oct 2008]. 
16 REDLARA. Red Latinoamerican de Reproduccion Assistida. Available at: http://www.redlara.com/ 
[Accessed 8 Oct 2008]. 
17 REDLARA. Accreditation Available at: http://www.redlara.com/ing/REGISTRO.ASP [Accessed 8 Oct 
2008]. 
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Table 1: Argentine Fertility Clinics Listed in the RLA 
Name of Private Institution Fertility Services & Procedures 
Offered 
Accredited 
or Affiliated 
Language of 
Clinic’s 
Website  
AMERIS – Centro de Fertilidad, 
Ginecologia y Urologia 
www.amerisbb.com.ar  
Site under construction Accredited  Spanish 
C.I.G.O.R Centro Integral de Ginecologia, 
Obstetricia y Reproduccion  
www.cigorcentro.com.ar 
Ovarian stimulation, IUI, IVF, ICSI, 
Oocyte Donation 
Accredited English 
Spanish 
CEFEP – Centro para la Fertilidad de la 
Pareja 
www.cepef.org.ar   
Site under construction Accredited NA 
CER Instituto Médico 
www.cermed.com 
Simply notes fertility 
treatment/services 
Accredited English 
CERH – Centro de Estudios en 
Reproduccion Humana 
NA Accredited Spanish 
CIMER – Centro de Invertigaciones en 
Medicina Reproductiva 
www.cimer.com 
IUI, IVF, ICSI, AH, Gametes 
donation, cryopreservation of 
gametes and embryos, 
study and diagnosis of partner, 
Ultrasound monitoring of the 
ovulation. 
Affiliated Spanish 
CRECER 
www.crecerreproduccion.com.ar 
IUI, IVF, ICSI, Cryopreservation of 
embryos 
Affiliated Spanish 
Centro Médico Fertilab 
www.fertilab.com.ar 
IUI, IVF ICSI, GIFT, ZIFT, 
Cryopreservation of embryos 
Accredited Spanish 
Centro de Estudios en Ginecologia y 
Reproduccion (CEGYR) 
www.cegyr.com 
IUI, IVF, ICSI, Cryopreservation of 
gametes and embryos, PGD, AH, 
Gametes donation 
Accredited Spanish 
English  
 
Centro de Reproduccion 
www.centrodereproduccion.com 
IUI, IVF, ICSI Accredited English 
Spanish 
Centro de la Mujer 
www.hospitalitaliano.org.ar 
General notes about services Accredited Spanish 
Fecundart – Instituto Integral de 
Reproduccion Asistida 
www.fecundart.com.ar  
IVF, GIFT, ICSI Accredited Spanish 
Fecunditas 
www.fecunditas.com / www.PGD-
Fecunditas.com  
IVF, AH, PGD, Gametes and 
Embryos donation, Cryopreservation 
of gametes and embryos 
Accredited English 
Spanish 
GENS – Centro Especializado en 
tratamientos para la mujer 
(web-site not available) 
NA Affiliated NA 
Halitus Instituto Médico 
www.halitus.com 
IVF, ICSI, Oocyte and embryo 
donation, PGD 
Accredited Spanish 
Instituto Prefer 
www.iprefer.com.ar 
IVF, IUI, GIFT, 
Cryopreservation of  gametes and 
embryos 
Oocyte donation, AH 
Accredited Spanish 
(Can answer 
questions in 
English) 
Instituto de Medicina Reproductiva 
www.institutomedicinareproductiva.com 
IVF, ICSI, IUI, Cryopreservation of 
gametes 
Accredited Spanish 
PROAR – Programa de Asistencia 
Reproductiva de Rosario 
www.proar-rosario.com.ar  
IVF, IUI, ICSI, GIFT, TET Accredited English  
Spanish 
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PROCREARTE – Red de Medicina 
Reproductiva y Molecular 
www.procrearte.com 
IVF, IUI, ICSI, GIFT, AH, 
Cryopreservation of embryos, PGD, 
Oocyte donation 
Accredited Spanish 
SERESA-Centro de Salud Reproductiva 
Salta 
www.saresa.com.ar 
IUI, IVF, ICSI 
Ovarien stimulation 
Accredited Spanish 
Unidad de Fertilisas San Isidro (UNIFER) 
www.unifer.com.ar  
NA Accredited NA 
Legend: In Vitro Fertilization (IVF); Intra Cytoplasmic Sperm injection (ICSI); Intra-Uterine Insemination 
(IUI), Assisted Hatching (AH), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), 
Tubal Embryo Transfer (TET), prenatal genetic diagnosis (PGD), Information unavailable at the time of 
this work (NA). 
 
2) The Web search 
Using the Google and Yahoo search engines, we conducted keyword searches for: ‘medical 
tourism’, ‘medical trips to Argentina’, ‘fertility clinics in Argentina’, and ‘reproduction clinics in 
Argentina’. The rationale for this approach was to simulate the search methods that a 
hypothetical ‘average health care consumer’ might use to shop for medical tourism services. 
The general web search identified some of the sites found in the RLA, as well as two additional 
fertility clinics, Plenitas and Go Sculptura (see Table 2).  
 
Table 2: Non-Accredited Private Argentine Fertility Clinics 
Name of Private 
Institution 
Fertility Services and 
Procedures Offered 
Prices 
(in $US) 
Services offered to medical 
tourists 
Language of 
Clinic’s Website 
IVF $4,795 
Oocyte donation $8,405 
Cryopreservation of 
Embryos 
$2,295 
ICSI $4,995 
Plenitas 
www.plenitas.com 
Cryopreservation of 
Sperm 
$995 
Including hotel stay, bilingual 
assistant, transportation 
 
Spanish 
English 
IVF $5,192 
Donor eggs & embryos $8,995 
Go Sculptura 
www.gosculptura.com  
ICSI $5,395 
Including hotel stay, personal 
assistant, relaxation 
packages 
Spanish 
English 
Legend: In Vitro Fertilization (IVF); Intra Cytoplasmic Sperm injection (ICSI). 
 
These two clinics are noteworthy because they do not appear in the registries (RLA or SAMeR), 
and thus raised questions concerning the degree of regulatory oversight of these clinics. 
Subsequent comparisons between the clinics listed in Tables 1 and 2 identified several 
particularities, which will be discussed in further detail below. Other non-Argentinean fertility 
clinics (e.g. in Brazil, Chile, and Mexico) that appeared in these search results were excluded 
from our analysis. 
 
Comparing accredited and non-accredited clinics 
The range of services offered by the accredited (and affiliated) and non-accredited clinics varies 
significantly. Accredited institutions typically offer a more extensive list of fertility procedures 
while the non-accredited clinics focus on more generic fertility procedures such as IVF and 
intracytoplasmic sperm injection (ICSI). The more complicated procedures that require invasive 
protocols such as intrauterine insemination (IUI) and gamete intrafallopian transfer (GIFT), are 
provided exclusively by accredited clinics. This is consistent with observations previously made 
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in the ethics and public policy literatures relating to the privatization of health care service 
provision; that is, profit-seeking institutions prefer to focus on the ‘low hanging fruit’ or the 
relatively uncomplicated therapies that can produce a high profit margin.18 Although all the 
accredited and non-accredited clinics are private entities, those clinics participating in the 
registries (SAMeR or RLA) and thus accepting some form of oversight appear to have adopted 
a less explicitly profit-seeking model of operation.  
 
Interestingly, many of the non-accredited Latin American fertility clinics that we found through 
our web search also operate within larger private medical institutions that provide a variety of 
other lucrative procedures, most notably cosmetic surgery. By contrast, accredited (or affiliated) 
fertility clinics specialise exclusively in fertility treatments; they do not provide non-fertility related 
services. There is also an important difference in the content and accessibility of websites of 
accredited and non-accredited clinics. In addition to having their own individual websites, both of 
the non-accredited clinics in our study – Plenitas and Go Sculptura – market themselves more 
widely on the Internet through links on general sites dedicated to medical or reproductive 
tourism, blogs and on-line forums. By contrast, the websites of the accredited clinics are almost 
exclusively linked to from the registries, and not from other commercial health care websites. 
Lastly, the non-accredited clinics typically highlight in their packages the availability of 
complementary tourist services, such as hotel accommodations or the aid of bilingual 
assistants; accredited clinics focus solely on describing the fertility services they offer. 
 
To summarise, we observed an emergence of two subcategories of private fertility practices in 
Argentina: 1) accredited and affiliated clinics – part of the general healthcare industry – 
providing a broad array of fertility services to both local and foreign populations, and 2) non-
accredited clinics specialised in providing a limited range of lucrative fertility services as part of 
medical tourism packages. 
 
DISCUSSION  
The private provision of fertility services raises numerous important ethical issues that merit 
further consideration, but for the purposes of this paper we will focus on those issues arising 
from a lack of regulatory oversight of non-accredited clinics. That is, we examine the 
implications of fixed or package pricing, the explicit targeting of Western consumers, and the 
selective disclosure of information for important medical procedures. 
 
Unlike the rather minimalist and often simple websites employed by most accredited clinics, the 
non-accredited clinics deploy very sophisticated and easy to navigate websites with appealing 
messages and presentation. Similar to the ‘all inclusive’ vacation packages offered by tourist 
resorts and travel agencies, Plenitas and Go Sculptura offer ‘all inclusive, full package’ deals. 
These include hotel accommodation, local transportation, and a personal bilingual assistant – as 
well as the fertility treatment – in one fixed price; this marketing tactic is also used by medical 
brokerage companies that offer services to facilitate the medical tourism experience.19 The 
appeal of such packages is obvious: health care consumers need not worry about any of the 
practical details of their trip (e.g. budgeting, travel arrangements, language barriers), and can 
instead focus on obtaining the quality medical services that they desire, combined with a 
vacation. Further, the non-accredited clinics in Argentina offer much more competitive prices for 
services in comparison with clinics in North America or Europe; for example, IVF in the US runs 
                                            
18 M. Gold. Can Managed Care and Competition Control Medicare Costs? Health Aff 2003; Jan-Jun: W3-
176-188. Available at: http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.176v1 [Accessed 8 Oct 2008]. 
19 L. Turner. First World Health Care at Third World Prices’: Globalization, Bioethics and Medical Tourism. 
Biosocieties 2007; 2: 303-325  
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upwards of US$10,000 per cycle of treatment (without any tourist-friendly add-ons), 
approximately double the price offered by Plenitas or Go Sculptura.  
 
However, fixed pricing can be contentious because it transforms complex and individually 
specific medical procedures into a ‘one-size-fits-all’ package. Economic studies conducted in 
the US have shown that there are a number of factors associated with specific and distinct 
physical attributes of a patient which would inevitably necessitate cost variations for a given 
ART procedure.20 So while fixed pricing may be an effective marketing tactic, it may not provide 
the flexibility required to adequately reflect cost increases incurred as a result of specific 
individual patient requirements. The clinic would thus have to factor into their standard package 
some margin to absorb unforeseen cost variations; while this might well be feasible, it also 
raises concerns about incentives to ‘cut corners’ in the quality of service if a patient treatment 
program becomes more complicated, and thus more expensive, than anticipated. We could not 
determine the true costs of fertility services in Argentina because accredited clinics (a 
reasonable standard for comparison pricing) provided no information online about the 
underlying cost elements or structure of their prices for a given fertility treatment, nor did non-
accredited clinics provide a break down of the exact costs that made up their fixed-price 
packages.  
 
To entice prospective clients, non-accredited clinics also use economic arguments, language 
and analogies that would be particularly familiar to Western audiences. For example, the 
Plenitas website mentions that there is ‘no catch’ and that the low prices offered are the result of 
advantageous exchange rates between the Argentine peso and the US dollar. In a clever 
comparison, the Plenitas website explains that a Big Mac bought in the US costs $3, while one 
purchased in Argentina would be only $1.6, thus highlighting the important price advantage for 
consumers accessing services in Argentina. ‘The Big Mac is exactly the same, but the price is 
related to the economy of the country where it is sold.’21 Yet such simple language, while a very 
effective means of describing the price difference, is not unproblematic. 
 
It is certainly the case that popular culture references (e.g. to the Big Mac) can help consumers 
better understand the reason for price differences. But such language can also contribute to the 
erroneous perception that specialized health services, such as ARTs, are not all that different 
from other consumer goods, such as tourist attractions and luxury hotel accommodations. 
Without entering into the larger debate about the ethics of public or private provision and/or 
purchase of health care services, it is still possible to make a convincing case that access to 
health care products and services – such as prescription medicines, surgeries, or ARTs – 
require special consideration because of the very great potential health risks involved (e.g. 
adverse drug reactions, hospital born infections) and the need for guidance and support by 
accredited medical professionals. In the case of fertility services, important risks include the 
birth of multiple low-weight babies and a higher incidence of fetal developmental abnormalities.  
 
We are not arguing that the commercial nature of private health care delivery necessarily entails 
an unjustified commodification of such services. Rather, it is our contention that the marketing of 
fertility services as part of reproductive tourism packages – as done by the non-accredited 
clinics examined in our study – camouflages or trivializes the importance of the risks involved. 
Indeed, prospective clients may well underestimate or overlook important considerations related 
                                            
20 M.E. McClure. 1996. The "ART" Of Medically Assisted Reproduction: An Embryo Is an Embryo Is an 
Embryo. In Birth to Death: Science and Bioethics. D.C. Thomasma and T.K. Kushner, eds. Cambridge: 
Cambridge University Press. 
21 Plenitas. Plenitas. Available at: http://www.plenitas.com [Accessed 8 Oct 2008]. 
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to quality of care, safety, and the regulation of health care services, factors that are critical to 
their own health.22 The notion of caveat emptor, or ‘buyer beware’, is insufficient protection in 
the case of reproductive or medical tourism. 
 
Another concern in the presentation or marketing of fertility services by the non-accredited 
clinics is related to their use of competitor rankings. For example, Plenitas differentiates itself – 
and Argentina more generally – as being a more favourable option for potential clients, in 
comparison with competitors in India, Poland, Colombia and Thailand. Using tables presenting 
comparative data on national populations, economy, social development, and health, the 
Plenitas website23 makes the case that Argentina has one of the highest literacy rates, GDP, 
industrial production growth rate, and most physicians per population. The clear implication is 
that Argentina is the most sophisticated or Western-like country, and thus consumers should not 
be concerned about quality or safety issues. However, it should be noted that Plenitas has 
advantageously selected competitors in poorer nations while carefully ignoring other popular 
and affordable destinations such as Mexico or Brazil, neighbouring countries that present stiffer 
competition in the medical tourism industry.24  
 
One can obviously make a clear distinction between legitimate positive corporate self-
promotion, and the presentation of misleading or false advertising, especially in comparison with 
competitors; the former is ethically and legally acceptable, the latter is not and is likely to 
provide the grounds for lawsuits. But the distinction becomes much harder to make when the 
promotion involves the presentation of selective or even slightly biased information. And, when 
there is limited access to impartial information sources about service providers – as is the case 
for the non-accredited clinics – consumers will be far less able to make informed decisions 
about the purchase of sophisticated and complex medical services.25 
 
A final point to consider is the relative ease of access in locating the websites of non-accredited 
clinics, in comparison to accredited (or affiliated) clinics. The former are quickly found with a 
simple Internet search (such as with Google), whereas the latter take much more effort and time 
to find. To expand, accredited clinics are found indirectly through registry websites and the 
information is usually available only in Spanish. (The REDLARA site is linked to from other 
fertility sites, but this is not evident when a direct Internet search is conducted.) Nor is it obvious 
from the information on the non-accredited websites that there are differences in accreditation 
(or what this entails) and regulation of fertility clinics. Thus it is reasonable to ask whether 
potential health care consumers have the capacity to differentiate between accredited or non-
accredited clinics, or even realise that the former are regulated by oversight bodies while the 
latter are not. 
 
Regulation, safety and consumer satisfaction 
It is not possible for democratic societies, whether they are in developed or developing 
countries, to protect their populations by regulating or controlling the quality or veracity of 
                                            
22 Turner. op cit. note 19. 
23 Plenitas. op cit. note 21. 
24 J. Davidow. 2006. Cost-Saving Surgery Lures 'Medical Tourists' Abroad. Seattle Post-Intelligencer's 24 
Jul. Available at: http://seattlepi.nwsource.com/health/278630_medtour24.html [Accessed 9 Oct 2008]. 
25 J. Huh & B.J. Cude. Is the Information ‘‘Fair and Balanced’’ in Direct-to-Consumer Prescription Drug 
Websites? Journal of Health Communication 2004; 9: 529–540; S.E. Gollust, S.C. Hull & B.S. Wilfond. 
Direct-to-Consumer Sales of Genetic Services on the Internet. Genetics in Medicine 2003; 5: 332–337 
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information presented by foreign companies on the Internet.26 However, it is possible for host 
countries to set standards by regulating the practices (e.g. in terms of marketing or laboratory 
quality) of local clinics, through general regulations on corporate advertising and focused 
national policies or registries (such as REDLARA or SAMeR).27 Most countries with advanced 
health care systems such as Canada, France, or the United Kingdom have policies and 
regulations to control the development, commercialization and use of health care services; 
reproductive technologies are no exception. In fact, the contentious nature of many ART 
procedures requires that they be subject to specific, and sometimes very restrictive, legislation 
and regulation.28 
 
In Latin America, Brazil and Mexico have some form of government regulation governing ART;29 
Argentina, lacking such regulation, relies on professional guidelines and national or regional 
registries.30 SAMeR and REDLARA, which as previously mentioned, oversee the operations of 
accredited and affiliated clinics (Table 1), regulate service quality, laboratory procedures and 
staff qualifications; notably, this does not include evaluation of marketing practices.31 According 
to the REDLARA website, 90% of fertility clinics in Latin America are registered and therefore 
regulated.32 The remaining 10%, such as the non-accredited clinics presented in this article, are 
not regulated by any external institution or oversight body. The only remaining possible 
regulation of these clinics would be through professional codes of ethics or internal institutional 
practice guidelines. 
 
Since there is no formal legislation in Argentina to empower oversight bodies to regulate all 
fertility clinics, the quality of procedures may vary widely.33 Oversight of health, safety or 
professional credentials is limited to the aforementioned national and regional registries, but 
accreditation through these registries is voluntary. There is no control over non-accredited 
fertility clinics such as Plenitas and Go Sculptura which chose not to be associated with the 
registries. The result is that non-accredited clinics have total discretion over how to run their 
clinics and which services to offer, and they are free from official oversight.34 
 
                                            
26 B. Williams-Jones. Where There's a Web, There's a Way: Commercial Genetic Testing and the 
Internet. Community Genet 2003; 6: 46-57; Gollust, Hull & Wilfond. op cit. note 25. 
27 Human Genetics Commission. 2003. Genes Direct: Ensuring the Effective Oversight of Genetic Tests 
Supplied Directly to the Public. London: Human Genetics Commission, Department of Health. Available 
at: http://www.hgc.gov.uk/UploadDocs/DocPub/Document/genesdirect_full.pdf [Accessed 9 Oct 2008]. 
28 House of Commons Science and Technology Committee (UK). 2005. Human Reproductive 
Technologies and the Law. London. Available at: 
http://www.publications.parliament.uk/pa/cm200405/cmselect/cmsctech/7/702.htm [Accessed 8 Oct 
2008]. 
29 In Brazil, ARTs are governed by a resolution from the federal medical council; in Mexico the subject of 
ARTs is lightly addressed in the “Ley General de Salud” although there are no specific considerations 
about, for example, consumer protection or the number of embryo’s that should be implanted. 
30 F. Luna. 2002. Assisted Reproductive Technology in Latin America: Some Ethical and Sociocultural 
Issues. Current Practices and Controversies in Assisted Reproduction 17-21 Sept 2001. Geneva: World 
Health Organisation. E. Vayena, P. Rowe and G. David, eds. 31-39. Available at: 
http://www.who.int/reproductive-health/infertility/7.pdf [Accessed 8 Oct 2008]. 
31 SAMeR. op cit. note 15. 
32 REDLARA. op cit. note 16. 
33 Luna. op cit. note 30. 
34 Pennings. op cit. note 9. 
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Safety and market interests 
In a free market, a company’s reputation will depend to a large extent on customer satisfaction, 
thus there is an incentive to produce or offer services and products that are safe and effective;35 
in the case of fertility services, this would mean that clinics have an interest in offering quality 
services that also have a high probability of resulting in a successful pregnancy. Medical tourists 
likely have high expectations, often travelling great distances expecting a one-time treatment 
with a successful outcome. There may be little acceptance of failure and the ensuing need to 
repeat the travel and the procedure. ARTs are not simple procedures, nor are they guaranteed 
to produce a live birth. Fertility treatments do allow many couples to conceive and deliver 
healthy babies, but as has been shown by numerous clinical and epidemiological studies, rates 
of ‘take home babies’ (which vary substantially between clinics) average only 15 to 30%; the 
chance of having a successful birth drops dramatically with each subsequent round of 
treatment. 
 
It is in the interest of both clients and service providers to maximise the chance of a successful 
pregnancy in the absence of medical complications, so in many cases this leads to the 
implantation of multiple embryos. There is evidence that in private fertility clinics, higher 
numbers of embryos are transferred in a given ART procedure, particularly in countries where 
private heath care systems predominate, such as in the United States and most of the 
developing world, including Latin America. One study found that the number of embryos 
implanted by fertility clinics in developing countries was double (4 on average) that of clinics in 
countries with predominantly socialized medicine (e.g. in Northern Europe or Australia).36 In 
these latter countries, clinics tend to implant fewer embryos in order to avoid the occurrence of 
multiple pregnancies and associated health risks (e.g. complications associated with the birth of 
multiple low weight babies), and reduce associated costs to national health care systems. So 
while some consumer and clinic interests may converge (high pregnancy rates at lower cost), 
there may also be divergence regarding such factors as the risks and costs to consumers and 
home country health care systems (minimizing rates of multiple births and expensive follow-up 
care). 
 
Final points for consideration are the role and associated accountability of foreign treating 
physicians, which may differ from those in the medical tourists’ home countries. The staff at 
non-accredited clinics such as Plenitas and Go Sculptura very likely offer quality services; the 
doctors at these two clinics have medical degrees from reputable universities and are 
specialists affiliated with major research hospitals and clinics. Nonetheless, it is still important 
for potential customers to consider the role of the treating physicians in Argentina. Unlike their 
personal physician in their home country, with whom patients have a fiduciary relationship – the 
physician has a responsibility to look out for the patient’s best interests – the foreign doctor is an 
employee of the private clinic that sells services in a relatively unregulated system. As such, the 
doctor is in a conflict of interest because of dual loyalties.37 As a doctor, his or her duty is to the 
patient (a duty based in professional codes of ethics), but as an employee of the clinic, the 
doctor is expected to sell the clinic’s services and deliver them within a prescribed cost structure 
limited by fixed price considerations (as discussed previously). Further, in practice the doctor’s 
responsibility ends when the patient leaves the clinic in Argentina; there are no mechanisms for 
follow-on or long-term supervision should such care be necessary. In short, the medical tourist 
                                            
35 H. Marcus, D. Marcus & S. Marcus. How Do Infertile Couples Choose Their IVF Centers? An Internet-
Based Survey. Fertil Steril 2005; 83: 779-781 
36 F. Luna. 2006. Bioethics and Vulnerability; a Latin American View. Amsterdam: Rodopi  
37 J.P. Kassirer. Financial Conflict of Interest: An Unresolved Ethical Frontier. Am J Law Med 2001; 27: 
149-162 
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must be aware that the patient-physician relationship differs significantly from the commercial 
business-client arrangement or contract for services.38   
 
Implications for the key actors involved in reproductive tourism 
The preceding analysis highlighted a number of concerns raised by the growing reproductive 
tourism industry. As discussed earlier, there are good arguments for both opponents and 
proponents of the practice of reproductive tourism. We do not argue here that this practice 
should be prohibited; private fertility clinics offer services that many people are willing to pay for, 
but which may not be considered (e.g. by decision makers) sufficiently important to warrant 
provision as part of public health insurance plans. Rather, our intent is to clarify the key 
implications and responsibilities for the actors involved (i.e. consumers, health professionals, 
policy makers, and civil society), in order to substantiate our claim that more formal regulatory 
mechanisms are necessary to encourage greater transparency and accountability, ensure safe 
clinical practices, and protect public health and welfare. 
 
Health Care Consumers 
As previously mentioned, many consumers looking to travel to Argentina to access fertility 
services are provided information on clinic websites that trivialises or under-represents the 
important risks involved in such procedures, or that offers only partial and ultimately self-serving 
facts. The consumer is often ill informed about important details of such treatments, including 
the possibility and/or need for follow-up care, which may well lead to unwise decisions or 
choices. As has been discussed in some detail in the ethics and policy literatures dealing with 
access to private health care (whether or not in the context of medical tourism), the consumer is 
reasonably thought of as an autonomous agent and as such responsible for his or her 
decisions.39 Accordingly, consumers of fertility services should select clinics carefully and 
evaluate related information, particularly where there is appropriate regulation and oversight 
(and thus some measure of quality assurance).40 But it would be unfair and unrealistic to ascribe 
to patients, as consumers, full responsibility for evaluating the quality and conduct of highly 
specialised and technical health care procedures; such capacities go well beyond what can be 
expected of even the most educated members of the general public. It is thus also important to 
consider the interests, roles and responsibilities of the other actors involved in the provision of 
private fertility services, something which has received comparatively little attention in the 
literature.  
  
Health Professionals 
Health professionals – as members of formal professions (i.e. with monopoly powers, 
professional independence, and social prestige) entrusted with a patient’s health – commonly 
have fiduciary relationships with their patients. While respect for patient autonomy, and thus 
decision making, is an important factor in most patient-physician relationships in North America 
and Europe, patients still seek medical professionals whom they can trust to provide advice that 
will be in the patient’s best interests. As we have shown, health professionals in private clinics, 
whether or accredited or not, may be in important conflicts of interest because of their dual 
loyalties (to patients and to their employer); this situation is only exacerbated in the case of 
health professionals working in non-accredited clinics operating in the medical tourism sector. 
These health professionals might be influenced to recommend patients to undertake more risky 
                                            
38 G. Pennings, et al. ESHRE Task Force on Ethics and Law 15: Cross-Border Reproductive Care. Hum 
Reprod 2008; 23: 2182-2184 
39 S.H. Woolf, et al. Promoting Informed Choice: Transforming Health Care to Dispense Knowledge for 
Decision Making. Ann Intern Med 2005; 143: 293-300 
40 Marcus, Marcus & Marcus. op cit. note 35. 
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medical practices (e.g. implantation of multiple embryos); and where there is little information 
about clinical outcomes (because gestation and actual birth occurs abroad, in the medical 
tourist’s home nation), and non-existent oversight and regulation, there may be few negative 
consequences associated with such risky medical practices.  
 
Health professionals in private clinics in developed countries may arguably be less inclined to 
engage in practices that could be deemed unprofessional, due to stringent oversight 
mechanisms and the potential for costly and professionally embarrassing law suits. By 
extension, in a competitive and increasingly global market for fertility services, private clinics in 
developed countries (but also in developing countries) may have a strong incentive to provide 
high quality services to attract medical tourists. Simply because a private clinic is non-accredited 
does not mean that it provides lower quality services than accredited clinics; but it is important 
to pay attention to the diverse and sometimes conflicting interests that are at stake. 
 
Policy Makers 
Many nations, in both the developed and developing worlds, have encouraged the practice of 
medical tourism because it has the potential to contribute to significant economic 
development.41 But if the safety and quality of care do not meet internationally recognised 
standards, or are not up to par with those of competing nations, then a country’s reputation as a 
medical tourism destination will eventually be compromised, thereby undermining market share 
and potential economic benefits. Thus alongside their obligation to protect public health, policy 
makers in countries such as Argentina that are developing medical tourism sectors also have an 
interest in implementing rigorous oversight mechanisms to ensure that the highest quality 
services are provided. Paradoxically, the case can be made that overly restrictive legislation 
controlling access to fertility services in developed countries actually encourages reproductive 
tourism.42  
 
Nonetheless, basic safety standards and quality control are still an essential element in the 
effective provision of fertility services; the challenge will be in deciding which specific 
mechanisms are most appropriate in light of social, cultural and economic differences. Policy 
makers and national leaders must recognize that implementing regulatory mechanisms may 
take considerable time, and that to be effective they will have to also consider other potentially 
competing interests, i.e. those of health professionals and private clinics. Although it can be 
agued that many developing economies such as Argentina lack the capacity to promote 
responsive regulation through top-down government legislation, these countries are not without 
alternatives. Local and international NGOs or established local and regional systems may be 
important mechanisms with which to regulate the private market.43 For instance, by building on 
already established registries such as SAMeR and REDLARA, and making their standards 
obligatory instead of voluntary (as is currently the case), Argentinean policy makers could 
contribute to both the health and wealth objectives.  
 
Developed countries such as a Canada, the United States or members states of the European 
Union already have well established oversight mechanisms to regulate public and private sector 
fertility clinics. But they also arguably have an interest in promoting the development of better 
regulations internationally.44 Since their citizens are increasingly opting to go abroad for 
                                            
41 Turner. op cit. note 19. 
42 G. Pennings. Legal Harmonization and Reproductive Tourism in Europe. Hum Reprod 2004; 19: 2689-
2694 
43 J. Braithwaite. Responsive Regulation and Developing Economies. World Dev 2006; 34: 884-898 
44 Pennings, et al. op cit. note 38. 
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reproductive services, developed countries will bear the costs of providing potentially costly 
follow-up care to returning citizens should they suffer eventual complications from accessing 
risky, less-then-optimal procedures abroad. This is particularly true in the case of fertility 
treatments where complications will only manifest themselves at a latter stage of pregnancy, 
long after the individual has returned home. 
 
Civil Society 
Fertility clinics in Argentina are for the most part private entities, offering services only to those 
who can pay or who have sufficient private health insurance coverage. Given that ARTs are not 
covered by public health insurance plans in Argentina (and thus are of limited access), one 
might argue that there is no specific interest for Argentinean civil society with regards to how 
such services are regulated. However, there may well be a trickle down affect on the 
Argentinean economy if the various actors involved in service provision adopt or permit risky 
medical practices. As already mentioned, an unregulated reproductive tourism sector runs the 
risk of clinics losing their reputation for quality service provision, with the result that medical 
tourists opt to purchase services from clinics in other countries. This could then have a negative 
impact on access to services, (e.g. if clinics close) for those Argentineans who can afford to 
purchase ARTs, as well threatening the long term development of quality fertility service 
provision in the country. 
 
CONCLUSION 
As relatively new players in the medical tourism industry, private clinics in Argentina are now 
offering a diversity of medical services, including access to assisted reproductive technologies. 
A comparative website analysis revealed the existence of two subcategories of private fertility 
clinics: 1) accredited and affiliated clinics that are part of the broader health care industry; and 
2) non-accredited clinics focused on medical tourism. Fertility clinics offer a wide variety of 
fertility services, often combined with other services and tourist features, for a fixed price. In this 
paper, we discussed a number of issues associated with medical tourism and related practices 
as evidenced in the practices of two non-accredited Argentinean fertility clinics, Plenitas and Go 
Sculptura.  
 
Whether or not one thinks that reproductive services should be made available for private 
purchase, it is clear that consumers are purchasing such services. We argue that countries such 
as Argentina that currently lack formal oversight mechanisms should enact legislation to 
regulate the conduct of private fertility clinics in order to ensure that consumer information is 
accurate and that services provided are safe and effective. Some medical facilities that cater to 
medical tourists seem to be moving towards ensuring provision of more responsible practices, 
and for example, are sending their doctors to reside abroad (in developed countries) in order to 
provide follow-up care.45 
 
Self-regulation of the fertility industry (by clinics and medical professionals) is an important step 
in the right direction, but is arguably still insufficient. It is our contention that both resident and 
medical tourist destination countries have a strong interest in promoting effective regulation of 
the fertility sector. Not only is it in the best interest of the patient, but it also makes good 
business sense for the resident country (e.g. in the developed world) to avoid costs resulting 
from health complications of its citizens, and for the foreign country providing medical tourism 
services to maintain client trust and ensure market share over time. Reproductive tourism is a 
                                            
45 R.C. Merrell, et al. Medical Tourism. Telemed J E Health 2008; 14: 14-20. Available at: 
http://www.liebertonline.com/doi/abs/10.1089/tmj.2008.9995 [Accessed 8 Oct 2008]. 
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growing phenomenon, one which has many socio-ethical implications for health care 
consumers, medical professionals, private clinics, and for policy makers. Without public, 
academic, and political reflection and action on the specific issues raised by reproductive 
tourism, the private provision of ARTs will continue to be under-regulated, lack minimal quality 
standards, and pose significant risks for both health care consumers and nations. 
